Cooper Financial Group

Position in GILD — Gilead Sciences, Inc.

CIK 1751581 IRVINE, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$556,275

-$243,987 QoQ

Shares Held

4,403

-23.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#1,330

of 2,266 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Cooper Financial Group holds $19,451,562 across 11 Drug Manufacturers - General names. GILD ranks #8 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	5,274	$6,325,794
2	AMGN	Amgen Inc	8,265	$2,992,921
3	ABBV	AbbVie Inc.	11,460	$2,883,794
4	JNJ	Johnson & Johnson	10,851	$2,755,828
5	AZN	Astrazeneca PLC	6,342	$1,202,570
6	MRK	Merck & Co., Inc.	8,089	$1,039,436
7	BMY	Bristol Myers Squibb Co	12,387	$713,738
8	GILD	Gilead Sciences, Inc. This page	4,403	$556,275

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$556,275	4,403	-23.3%	Shares	Sole	2026-07-08
2026-03-31	$800,262	5,742	+21.5%	Shares	Sole	2026-04-07
2025-12-31	$580,191	4,727	+14.7%	Shares	Sole	2026-01-08
2025-09-30	$457,320	4,120	+58.3%	Shares	Sole	2025-10-07
2025-06-30	$288,594	2,603	+11.1%	Shares	Sole	2025-07-18
2025-03-31	$262,421	2,342	-67.5%	Shares	Sole	2025-05-12
2024-06-30	$494,609	7,209	+162.5%	Shares	Sole	2024-07-15
2024-03-31	$201,144	2,746	-9.6%	Shares	Sole	2024-04-11
2023-12-31	$246,027	3,037	+4.2%	Shares	Sole	2024-01-16
2023-03-31	$241,857	2,915	+22.9%	Shares	Sole	2023-05-11
2022-12-31	$203,636	2,372	-48.3%	Shares	Sole	2023-01-13
2020-06-30	$352,692	4,584	+1.8%	Shares	Sole	2020-07-15
2020-03-31	$336,719	4,504	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.